Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REBACARE Trial
2017-000949-53Phase 4Completed
- Sponsor
- Erasmus MC
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of mitomycin c in upper tract urothelial carcinoma (UTUC) (2 arms), sponsored by Erasmus MC. Started Apr 2017; status: completed.
02
Drugs
mitomycin c
03
Conditions
upper tract urothelial carcinoma (UTUC)
Beyond the preview
Go deeper on 2017-000949-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000949-53.